Ortho Clinical Diagnostics Holdings plc (OCDX) Financial Statements (2026 and earlier)

Company Profile

Business Address 1001 ROUTE 202
RARITAN, NJ 08869
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments309,700255,900200,900153,800
Cash and cash equivalent309,700255,900200,900153,800
Receivables257,200237,800226,400324,100
Inventory, net of allowances, customer advances and progress billings305,400308,300305,000291,100
Inventory305,400308,300305,000291,100
Other current assets139,400141,800136,600150,800
Total current assets:1,011,700943,800868,900919,800
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization791,400782,600799,500805,600
Intangible asset, including goodwill, after accumulated amortization1,452,8001,483,3001,529,1001,559,500
Goodwill573,600570,800578,400576,100
Intangible asset, excluding goodwill, after accumulated amortization879,200912,500950,700983,400
Deferred income tax assets9,7007,1007,3007,800
Other noncurrent assets98,20093,00099,50099,800
Other undisclosed noncurrent assets  100(100) 
Total noncurrent assets:2,352,1002,366,1002,435,3002,472,700
TOTAL ASSETS:3,363,8003,309,9003,304,2003,392,500
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities480,600390,800377,000391,200
Accounts payable181,000139,300146,400130,300
Accrued liabilities299,600251,500230,600260,900
Deferred revenue34,50032,60036,60034,300
Debt63,40064,40065,600139,400
Other undisclosed current liabilities  (100)(100) 
Total current liabilities:578,500487,700479,100564,900
Noncurrent Liabilities
Long-term debt and lease obligation, including:2,186,7002,206,9002,229,4002,240,300
Other undisclosed long-term debt and lease obligation2,186,7002,206,9002,229,4002,240,300
Liabilities, other than long-term debt188,100218,500220,100210,700
Deferred income tax liabilities72,10084,40081,50068,000
Liability, pension and other postretirement and postemployment benefits37,10039,90039,60038,900
Other liabilities78,90094,20099,000103,800
Other undisclosed noncurrent liabilities  (100)100 
Total noncurrent liabilities:2,374,8002,425,3002,449,6002,451,000
Total liabilities:2,953,3002,913,0002,928,7003,015,900
Equity
Equity, attributable to parent410,500396,900375,600376,600
Preferred stock100100100100
Additional paid in capital2,425,9002,419,7002,407,0002,394,300
Accumulated other comprehensive loss(43,700)(61,000)(54,900)(61,200)
Accumulated deficit(1,971,800)(1,961,900)(1,976,600)(1,956,600)
Other undisclosed equity   (100) 
Total equity:410,500396,900375,500376,600
TOTAL LIABILITIES AND EQUITY:3,363,8003,309,9003,304,2003,392,500

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
Revenues521,000522,500492,500506,800
Cost of revenue(258,100)(252,400)(248,100)(248,200)
Cost of product and service sold (252,400)(248,100)(248,200)
Gross profit:262,900270,100244,400258,600
Operating expenses(52,700)(206,300)(202,600)(160,400)
Other operating expense, net(19,800)(9,800)(10,500)(7,400)
Other undisclosed operating loss(159,300)  (33,400)
Operating income:31,10054,00031,30057,400
Nonoperating income (expense)(40,300)3,300(4,700)(49,100)
Gain (loss), foreign currency transaction, before tax (38,000)700(1,300)900
Other nonoperating income (expense)(2,300)2,600(3,400)(50,000)
Interest and debt expense(33,500)(36,100)(33,000)(93,700)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes (52,800)(41,900)1,50049,600
Income (loss) from continuing operations before equity method investments, income taxes:(95,500)(20,700)(4,900)(35,800)
Other undisclosed income from continuing operations before income taxes89,50041,400  
Income (loss) from continuing operations before income taxes:(6,000)20,700(4,900)(35,800)
Income tax expense(3,900)(6,000)(15,100)(3,300)
Income (loss) from continuing operations:(9,900)14,700(20,000)(39,100)
Income (loss) before gain (loss) on sale of properties:(9,900)14,700(20,000)(39,100)
Net income (loss) available to common stockholders, diluted:(9,900)14,700(20,000)(39,100)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
Net income (loss):(9,900)14,700(20,000)(39,100)
Other comprehensive income (loss)17,200(5,900)6,3007,200
Comprehensive income (loss):7,3008,800(13,700)(31,900)
Other undisclosed comprehensive loss, net of tax, attributable to parent  (100)  
Comprehensive income (loss), net of tax, attributable to parent:7,3008,700(13,700)(31,900)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: